Patents

US 10351574 B2: Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same

Granted
2019-07-16
Filed
2017-10-12 application 15730885
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Compositions comprising hydrocodone benzoic acid enol ester to form novel prodrugs including hydrocodone benzoic acid enol ester salts, and various polymorphs. Also provided are processes for the preparation of hydrocodone benzoic acid enol ester salts, and various polymorphs.

Source: PVGPATDIS, file of 2026-04-10 (ipg190716.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
KEMPHARM, INC. 57 patentsUS company or organizationFour Corners, FLKEMPHARM, INC Form D issuer EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Travis MickleWinter Garden, FL83PVGPATDIS, file of 2026-04-10
Sven GuentherCoralville, IA63PVGPATDIS, file of 2026-04-10
Christal MickleCoralville, IA18PVGPATDIS, file of 2026-04-10
Guochen ChiNorth Liberty, IA41PVGPATDIS, file of 2026-04-10
Jaroslaw KanskiBlacksburg, VA30PVGPATDIS, file of 2026-04-10
Andrea K. MartinFincastle, VA30PVGPATDIS, file of 2026-04-10
Bindu BeraBlacksburg, VA29PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D489/04PVGPATDIS, file of 2026-04-10
A61KPreparations for medical, dental or toiletry purposesA61K31/485PVGPATDIS, file of 2026-04-10
C07BGeneral methods of organic chemistry; apparatus thereforC07B2200/13PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-03-13Release of security interest
Release of security interest
ALTER DOMUS (US) LLC signed 2026-03-12ZEVRA THERAPEUTICS, INC. CELEBRATION, FL75080/907PASDL, file of 2026-10-15
2024-04-08Security interest Security interest
Security interest
ZEVRA THERAPEUTICS, INC. signed 2024-04-05ALTER DOMUS (US) LLC CHICAGO, IL67040/637PASDL, file of 2026-10-15
2024-02-23Name change
Change of name
KEMPHARM, INC. signed 2023-02-21ZEVRA THERAPEUTICS, INC. CELEBRATION, FL66664/108PASDL, file of 2026-10-15
2019-03-25Correction
Corrective assignment to correct the assignee address previously recorded at reel: 048387 frame: 0656. assignor(s) hereby confirms the assignment.
GUENTHER, SVEN signed 2019-01-16
MICKLE, CHRISTAL signed 2019-01-16
MICKLE, TRAVIS signed 2019-01-16
KANSKI, JAROSLAW signed 2019-01-17
MARTIN, ANDREA K. signed 2019-01-22
BERA, BINDU signed 2019-01-24
CHI, GUOCHEN signed 2019-01-25
KEMPHARM, INC. CELEBRATION, FL48691/373ECORSEXC, file of 2026-09-25
2019-02-20Assignment
Assignment of assignor's interest
GUENTHER, SVEN signed 2019-01-16
MICKLE, CHRISTAL signed 2019-01-16
MICKLE, TRAVIS signed 2019-01-16
KANSKI, JAROSLAW signed 2019-01-17
MARTIN, ANDREA K. signed 2019-01-22
BERA, BINDU signed 2019-01-24
CHI, GUOCHEN signed 2019-01-25
KEMPHARM, INC., CELEBRATION, FL48387/656ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.